Gemini, Sequenom Shareholders Approve Merger; September Close Sought | GenomeWeb

NEW YORK, Aug. 24 – Shareholders of UK-based Gemini Genomics and US-based Sequenom have approved the firms’ plans to merge, the companies said on Thursday.

The combined company, which will retain the name Sequenom, must still obtain approval from the High Court of Justice in England and Wales. The companies anticipate the deal to close at the end of September.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.